{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:32:18Z","timestamp":1794061938363,"version":"4.8.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,7,15]]},"DOI":"10.2169\/internalmedicine.8659-21","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T22:23:42Z","timestamp":1657837422000},"page":"2103-2109","source":"Crossref","is-referenced-by-count":5,"title":["The Optimal Cut-off of the Latex Immunoassay (LZ Test) for &lt;i&gt;Helicobacter pylori&lt;\/i&gt; Infection Based on the Stool Antigen Test and &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-associated Gastritis"],"prefix":"10.2169","volume":"61","author":[{"given":"Takako","family":"Takayama","sequence":"first","affiliation":[{"name":"Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Japan"},{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Japan"},{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Okada","sequence":"additional","affiliation":[{"name":"Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Japan"},{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Narasaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Maruo","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichiro","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Burucoa C, Delchier JC, Courillon-Mallet A, et al. Comparative evaluation of 29 commercial <i>Helicobacter pylori<\/i> serological kits. Helicobacter 18: 169-179, 2013.","DOI":"10.1111\/hel.12030"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Toyoshima O, Nishizawa T, Arita M, et al. <i>Helicobacter pylori<\/i> infection in subjects negative for high titer serum antibody. World J Gastroenterol 24: 1419-1428, 2018.","DOI":"10.3748\/wjg.v24.i13.1419"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A serum antibody test kit (E plate) for evaluation of <i>Helicobacter pylori<\/i> eradication. Intern Med 41: 780-783, 2002.","DOI":"10.2169\/internalmedicine.41.780"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kato M, Ota H, Okuda M, et al. Guidelines for the management of <i>Helicobacter pylori<\/i> infection in Japan: 2016 Revised Edition. Helicobacter 24: e12597, 2019.","DOI":"10.1111\/hel.12597"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kawai S, Arai K, Lin Y, et al. Comparison of the detection of <i>Helicobacter pylori<\/i> infection by commercially available serological testing kits and the <sup>13<\/sup>C-urea breath test. J Infect Chemother 25: 769-773, 2019.","DOI":"10.1016\/j.jiac.2019.03.026"},{"key":"6","unstructured":"6. Kawai T, Ito M, Aoyama N, et al. Evaluation of gastric cancer risk by optimized serum antibody titers against H. pylori: a multi-center retrospective study. Nihon Hericobactor Gakkai shi (Jpn J Helicobacter Res) 19: 133-138, 2017 (in Japanese, Abstract in English)."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Tsutsumi K, Kusano C, Suzuki S, Gotoda T, Murakami K. Diagnostic accuracy of latex agglutination turbidimetric immunoassay in screening adolescents for <i>Helicobacter pylori<\/i> infection in Japan. Digestion 98: 75-80, 2018.","DOI":"10.1159\/000487184"},{"key":"8","unstructured":"8. Aoyama N, Shigeta S, Yokozaki H. Comparison of H. pylori antibody between E-plate (ELISA) and latex agglutination method (LATEX) among strictly diagnosed H. pylori infection status. Nihon Hericobactor Gakkai shi (Jpn J Helicobacter Res) 18: 4-11, 2017 (in Japanese, Abstract in English)."},{"key":"9","unstructured":"9. Ito M, Aoyama N, Furuta T, et al. Evaluation of gastric cancer risk by optimized serum antibody titers against H. pylori: a multi-center retrospective study (second report). Nihon Hericobactor Gakkai shi (Jpn J Helicobacter Res) 22: 51-57, 2020 (in Japanese, Abstract in English)."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Jung Mook, Kang NK. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after <i>Helicobacter pylori<\/i> eradication: a three-year follow-up study in Korea. Helicobacter 17: 86-95, 2012.","DOI":"10.1111\/j.1523-5378.2011.00918.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miki K. Gastric cancer screening by combined assay for serum anti-<i>Helicobacter pylori<\/i> IgG antibody and serum pepsinogen levels - &quot;ABC method&quot;. Proc Jpn Acad Ser B Phys Biol Sci 87: 405-414, 2011.","DOI":"10.2183\/pjab.87.405"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamaguchi Y, Nagata Y, Hiratsuka R, et al. Gastric cancer screening by combined assay for serum anti-<i>Helicobacter pylori<\/i> IgG antibody and serum pepsinogen levels - the ABC method. Digestion 93: 13-18, 2016.","DOI":"10.1159\/000441742"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Taniyama Y, Katanoda K, Charvat H, et al. Estimation of lifetime cumulative incidence and mortality risk of gastric cancer. Jpn J Clin Oncol 47: 1097-1102, 2017.","DOI":"10.1093\/jjco\/hyx128"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ikeda F, Shikata K, Hata J, et al. Combination of <i>Helicobacter pylori<\/i> antibody and serum pepsinogen as a good predictive tool of gastric cancer incidence: 20-year prospective data from the Hisayama Study. J Epidemiol 26: 629-636, 2016.","DOI":"10.2188\/jea.JE20150258"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sato M, Shimoyama T, Takahashi R, et al. Characterization and usefulness of stool antigen tests using a monoclonal antibody to <i>Helicobacter pylori<\/i> catalase. J Gastroenterol Hepatol 27 (Suppl 3): 23-28, 2012.","DOI":"10.1111\/j.1440-1746.2012.07066.x"},{"key":"16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"1","author":"K Kimura","year":"1969","unstructured":"16. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1: 87-97, 1969.","journal-title":"Endoscopy","ISSN":"https:\/\/id.crossref.org\/issn\/0013-726X","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Sugano K, Tack J, Kuipers EJ, et al.; faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on <i>Helicobacter pylori<\/i> gastritis. Gut 64: 1353-1367, 2015.","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kishikawa H, Kimura K, Ito A, et al. Cut-off pepsinogen level for predicting unintendedly eradicated cases of <i>Helicobacter pylori<\/i> infection in subjects with seemingly normal pepsinogen levels. Digestion 95: 229-236, 2017.","DOI":"10.1159\/000469705"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Toyoda K, Furusyo N, Ihara T, Ikezaki H, Urita Y, Hayashi J. Serum pepsinogen and <i>Helicobacter pylori<\/i> infection - a Japanese population study. Eur J Clin Microbiol Infect Dis 31: 2117-2124, 2012.","DOI":"10.1007\/s10096-011-1543-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chinda D, Shimoyama T, Mikami T, et al. Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study. J Gastroenterol 53: 924-931, 2018.","DOI":"10.1007\/s00535-018-1431-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 101: 1921-1930, 2006.","DOI":"10.1111\/j.1572-0241.2006.00668.x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Vaira D, Vakil N. Blood, urine, stool, breath, money, and <i>Helicobacter pylori<\/i>. Gut 48: 287-289, 2001.","DOI":"10.1136\/gut.48.3.287"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/14\/61_8659-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:17:25Z","timestamp":1715231845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/14\/61_8659-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8659-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"8659-21"}}